Thyrotoxicosis as a Risk Factor for Pulmonary Arterial Hypertension

  1. Ronald C. Ma, MB BChir; and
  2. Chun Chung Chow, MBBS
  1. From Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.

    TO THE EDITOR:

    Although Rubin and associates (1) pointed out the importance of assessing patients with pulmonary arterial hypertension (PAH) for underlying autoimmune–collagen vascular disease, the need to assess for thyroid dysfunction and autoimmune thyroid disease was not addressed. Previous studies have suggested a …

    « Previous | Next Article »Table of Contents